This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ouali, R. Articles by Saez, J. M. Search for Related Content PubMed PubMed Citation Articles by Ouali, R. Articles by Saez, J. M.

Angiotensin II Receptor Subtypes AT1 and AT2 Are Down-Regulated by Angiotensin II through AT1 Receptor by Different Mechanisms¹

INSERM-INRA U-418, Hôpital Debrousse, Lyon, France

Address all correspondence and requests for reprints to: Dr. J. M. Saez, INSERM-INRA U-418, Hôpital Debrousse, 69322 Lyon Cedex 05, France.

The regulatory effects of angiotensin II (AngII) on its receptor subtypes, AT₁ and AT₂, were studied using cultured bovine adrenal cells (BAC), which express both receptor subtypes, and PC12W and R3T3 cells, which express only AT₂ receptors. In BAC, AngII caused a decrease in AT₁- and AT₂-binding sites and their corresponding messenger RNAs (mRNAs), but with different kinetics. AT₁-binding sites decreased by more than 50% within the first 3 h, whereas AT₁ mRNA started to decline after a lag period of 3 h. Both AT₂-binding sites and mRNA remained stable within the first 6 h of AngII treatment. Then, AT₂ mRNA decreased rapidly with an apparent half-life of 2–3 h, whereas AT₂-binding sites declined with an apparent half-life of about 16 h. Measurement of transcription rate and mRNA half-life by the [³H]uridine-thiouridine method revealed that AngII reduced by 90% the rate of AT₁ transcription, but had no effect on AT₁ mRNA half-life, whereas it slightly reduced AT₂ transcription, but markedly reduced AT₂ mRNA stability. All of the effects of AngII on both AT₁ and AT₂ receptors were blocked by losartan, indicating that they were mediated exclusively through the AT₁ receptor. In PC12W cells, AngII was unable to modify AT₂-binding sites or mRNA. Moreover, in BAC, [¹²⁵I]AngII was internalized through the AT₁ receptor, whereas occupancy of AT₂ receptors in either BAC or PC12W did not produce internalization of the hormone. These results indicate that AngII, through the AT₁ receptor, down-regulates both AT₁ and AT₂, but by different mechanisms; AT1 receptor is regulated through internalization-degradation of the occupied receptor and inhibition of transcription, whereas AT2 receptor is regulated mainly by decreasing the stability of its mRNA. Moreover, the phorbol ester phorbol 12-myristate 13-acetate mimicked most of the effects of AngII in BAC and decreased both AT₂-binding sites and mRNA on PC12W cells, indicating that the hormonal regulation of both AT₁ and AT₂ receptors is mediated through protein kinase C activation.

This article has been cited by other articles:

				A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors In Vivo, September 1, 2009; 23(5): 797 - 812. [Abstract] [Full Text] [PDF]

				Kai Chen, D. C. Merrill, and J. C. Rose The Importance of Angiotensin II Subtype Receptors for Blood Pressure Control During Mouse Pregnancy Reproductive Sciences, October 1, 2007; 14(7): 694 - 704. [Abstract] [PDF]

				D. G Romero, M. Y. Zhou, L. L Yanes, M. W Plonczynski, T. R Washington, C. E Gomez-Sanchez, and E. P Gomez-Sanchez Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion J. Endocrinol., August 1, 2007; 194(2): 429 - 440. [Abstract] [Full Text] [PDF]

				B. Plouffe, M.-O. Guimond, H. Beaudry, and N. Gallo-Payet Role of Tyrosine Kinase Receptors in Angiotensin II AT2 Receptor Signaling: Involvement in Neurite Outgrowth and in p42/p44mapk Activation in NG108-15 Cells Endocrinology, October 1, 2006; 147(10): 4646 - 4654. [Abstract] [Full Text] [PDF]

				S Ewert, T Sjoberg, B Johansson, A Duvetorp, M Holm, and L Fandriks Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat Exp Physiol, January 1, 2006; 91(1): 191 - 199. [Abstract] [Full Text] [PDF]

				S. Bedard, B. Sicotte, J. St-Louis, and M. Brochu Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction J. Physiol., February 1, 2005; 562(3): 937 - 950. [Abstract] [Full Text] [PDF]

				A. Heydorn, B. P. Sondergaard, B. Ersboll, B. Holst, F. C. Nielsen, C. R. Haft, J. Whistler, and T. W. Schwartz A Library of 7TM Receptor C-terminal Tails: INTERACTIONS WITH THE PROPOSED POST-ENDOCYTIC SORTING PROTEINS ERM-BINDING PHOSPHOPROTEIN 50 (EBP50), N-ETHYLMALEIMIDE-SENSITIVE FACTOR (NSF), SORTING NEXIN 1 (SNX1), AND G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN (GASP) J. Biol. Chem., December 24, 2004; 279(52): 54291 - 54303. [Abstract] [Full Text] [PDF]

				A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF]

				C. T. Sangaleti, A. Crescenzi, and L. C. Michelini Endogenous Angiotensin and Pressure Modulate Brain Angiotensinogen and AT1A mRNA Expression Hypertension, February 1, 2004; 43(2): 317 - 323. [Abstract] [Full Text] [PDF]

				F. Aguilar, M. Lo, B. Claustrat, J. M. Saez, J. Sassard, and J. Y. Li Hypersensitivity of the Adrenal Cortex to Trophic and Secretory Effects of Angiotensin II in Lyon Genetically-Hypertensive Rats Hypertension, January 1, 2004; 43(1): 87 - 93. [Abstract] [Full Text] [PDF]

				A. Forte, S. Esposito, M. De Feo, U. Galderisi, C. Quarto, F. Esposito, A. Renzulli, L. Berrino, M. Cipollaro, L. Agozzino, et al. Stenosis progression after surgical injury in Milan hypertensive rat carotid arteries Cardiovasc Res, December 1, 2003; 60(3): 654 - 663. [Abstract] [Full Text] [PDF]

				D. E. Zak, G. E. Gonye, J. S. Schwaber, and F. J. Doyle III Importance of Input Perturbations and Stochastic Gene Expression in the Reverse Engineering of Genetic Regulatory Networks: Insights From an Identifiability Analysis of an In Silico Network Genome Res., November 1, 2003; 13(11): 2396 - 2405. [Abstract] [Full Text] [PDF]

				L. Gendron, J.-F. Oligny, M. D. Payet, and N. Gallo-Payet Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 Cells J. Biol. Chem., January 31, 2003; 278(6): 3606 - 3614. [Abstract] [Full Text] [PDF]

				J. G. Modrall, M. Nanamori, J. Sadoshima, D. C. Barnhart, J. C. Stanley, and R. R. Neubig ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling Am J Physiol Cell Physiol, September 1, 2001; 281(3): C801 - C809. [Abstract] [Full Text] [PDF]

				D. T. Dinh, A. G. Frauman, M. Sourial, D. J. Casley, C. I. Johnston, and M. E. Fabiani Identification, Distribution, and Expression of Angiotensin II Receptors in the Normal Human Prostate and Benign Prostatic Hyperplasia Endocrinology, March 1, 2001; 142(3): 1349 - 1356. [Abstract] [Full Text] [PDF]

				H. Peng, J. Moffett, J. Myers, X. Fang, E. K. Stachowiak, P. Maher, E. Kratz, J. Hines, S. J. Fluharty, E. Mizukoshi, et al. Novel Nuclear Signaling Pathway Mediates Activation of Fibroblast Growth Factor-2 Gene by Type 1 and Type 2 Angiotensin II Receptors Mol. Biol. Cell, February 1, 2001; 12(2): 449 - 462. [Abstract] [Full Text]

				P. M. Fernandez, F. Brunel, M. A. Jimenez, J. M. Saez, S. Cereghini, and M. M. Zakin Nuclear Receptors Nor1 and NGFI-B/Nur77 Play Similar, Albeit Distinct, Roles in the Hypothalamo-Pituitary-Adrenal Axis Endocrinology, July 1, 2000; 141(7): 2392 - 2400. [Abstract] [Full Text] [PDF]

				C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase Endocrinology, May 1, 2000; 141(5): 1599 - 1607. [Abstract] [Full Text] [PDF]

				E. Chamoux Involvement of the Angiotensin II Type 2 Receptor in Apoptosis during Human Fetal Adrenal Gland Development J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4722 - 4730. [Abstract] [Full Text]

				J. Y. Li, O. Avallet, M. C. Berthelon, D. Langlois, and J. M. Saez Transcriptional and Translational Regulation of Angiotensin II Type 2 Receptor by Angiotensin II and Growth Factors Endocrinology, November 1, 1999; 140(11): 4988 - 4994. [Abstract] [Full Text]

				B. Adams, T. S. Obertone, X. Wang, and T. J. Murphy Relationship between Internalization and mRNA Decay in Down-Regulation of Recombinant Type 1 Angiotensin II Receptor (AT1) Expression in Smooth Muscle Cells Mol. Pharmacol., June 1, 1999; 55(6): 1028 - 1036. [Abstract] [Full Text]

				D. H. Wang, J. Qiu, and Z. Hu Differential Regulation of Angiotensin II Receptor Subtypes in the Adrenal Gland : Role of Aldosterone Hypertension, July 1, 1998; 32(1): 65 - 70. [Abstract] [Full Text] [PDF]

				J.-G. LeHoux, I. M. Bird, N. Briere, D. Martel, and L. Ducharme Influence of Dietary Sodium Restriction on Angiotensin II Receptors in Rat Adrenals Endocrinology, December 1, 1997; 138(12): 5238 - 5247. [Abstract] [Full Text] [PDF]

				D. E. Richard, S. A. Laporte, S. G. Bernier, R. Leduc, and G. Guillemette Desensitization of AT1 Receptor-Mediated Cellular Responses Requires Long Term Receptor Down-Regulation in Bovine Adrenal Glomerulosa Cells Endocrinology, September 1, 1997; 138(9): 3828 - 3835. [Abstract] [Full Text] [PDF]